The role of Interleukin-22 in severe acute pancreatitis.

IF 6 2区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Molecular Medicine Pub Date : 2024-05-15 DOI:10.1186/s10020-024-00826-7

Hongli Yang, Ruofan Cao, Feifei Zhou, Ben Wang, Qianqian Xu, Rui Li, ChunHua Zhang, Hongwei Xu

引用次数: 0

Abstract

Severe acute pancreatitis (SAP) begins with premature activation of enzymes, promoted by the immune system, triggering a potential systemic inflammatory response that leads to organ failure with increased mortality and a bleak prognosis. Interleukin-22 (IL-22) is a cytokine that may have a significant role in SAP. IL-22, a member of the IL-10 cytokine family, has garnered growing interest owing to its potential tissue-protective properties. Recently, emerging research has revealed its specific effects on pancreatic diseases, particularly SAP. This paper provides a review of the latest knowledge on the role of IL-22 and its viability as a therapeutic target in SAP.

查看原文本刊更多论文

白细胞介素-22在重症急性胰腺炎中的作用。

重症急性胰腺炎（SAP）始于酶的过早活化，在免疫系统的促进下，引发潜在的全身炎症反应，导致器官衰竭，死亡率升高，预后不良。白细胞介素-22（IL-22）是一种细胞因子，可能在 SAP 中发挥重要作用。IL-22是IL-10细胞因子家族的成员，由于其潜在的组织保护特性而越来越受到关注。最近，新出现的研究揭示了它对胰腺疾病，尤其是 SAP 的特殊作用。本文综述了有关 IL-22 的作用及其作为 SAP 治疗靶点的可行性的最新知识。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Molecular Medicine 医学-生化与分子生物学

CiteScore

8.60

自引率

0.00%

发文量

137

审稿时长

1 months

期刊介绍： Molecular Medicine is an open access journal that focuses on publishing recent findings related to disease pathogenesis at the molecular or physiological level. These insights can potentially contribute to the development of specific tools for disease diagnosis, treatment, or prevention. The journal considers manuscripts that present material pertinent to the genetic, molecular, or cellular underpinnings of critical physiological or disease processes. Submissions to Molecular Medicine are expected to elucidate the broader implications of the research findings for human disease and medicine in a manner that is accessible to a wide audience.